Recommended Child and Adolescent Immunization Schedule

1 Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger, UNITED STATES, 2018 Approved by the Advisory Committee on Immunization Practices ( )American Academy of Pediatrics ( )American Academy of Family Physicians ( )American College of Obstetricians and Gynecologists( ) Consult relevant ACIP statements for detailed recommendations ( ). When a vaccine is not administered at the Recommended age, administer at a subsequent visit. Use combination vaccines instead of separate injections when appropriate. Report clinically significant adverse events to the vaccine Adverse Event Reporting System (VAERS) online ( ) or by telephone (800-822-7967).

2 Report suspected cases of reportable vaccine -preventable diseases to your state or local health department. For information about precautions and contraindications, see Department of Health and Human ServicesCenters for Disease Control and PreventionVaccine type AbbreviationBrand(s)Diphtheria, tetanus, and acellular pertussis vaccineDTa PDaptacelInfanrixDiphtheria, tetanus vaccineDTNo Trade NameHaemophilus influenzae type B vaccineHib (PRP-T)Hib (PRP-OMP)ActHIBH iberixPedvaxHIBH epatitis A vaccineHepAHavrixVaqtaHepatitis B vaccineHepBEngerix-BRecombivax HBHuman papillomavirus vaccineHPVG ardasil 9 Influenza vaccine (inactivated)

3 IIVM ultipleMeasles, mumps, and rubella vaccineMMRM-M-R IIMeningococcal serogroups A, C, W, Y vaccineMenACWY-DMenACWY-CRMM enactraMenveoMeningococcal serogroup B vaccineMenB-4 CMenB-FHbpBexseroTrumenbaPneumococcal 13-valent conjugate vaccinePCV13 Prevnar 13 Pneumococcal 23-valent polysaccharide vaccinePPSV23 PneumovaxPoliovirus vaccine (inactivated)IPVIPOLR otavirus vaccinesRV1RV5 RotarixRotaTeqTetanus, diphtheria, and acellular pertussis vaccineTdapAdacelBoostrixTetanus and diphtheria vaccineTdTenivacNo Trade NameVaricella vaccineVARV arivaxCombination VaccinesDTaP, hepatitis B and inactivated poliovirus vaccineDTaP-HepB-IPVP ediarixDTaP, inactivated poliovirus and Haemophilus influenzae type B vaccineDTaP-IPV/HibPentacelDTaP and inactivated poliovirus vaccineDTaP-IPVK inrixQuadracelMeasles, mumps, rubella.

4 And varicella vaccinesMMRVProQuadThis Schedule includes recommendations in effect as of January 1, table below shows vaccine acronyms, and brand names for vaccines routinely recommend-ed for children and adolescents. The use of trade names in this Immunization Schedule is for identification purposes only and does not imply endorsement by the ACIP or 1. Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger United States, 2018. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP Schedule [FIGURE 2]). These recommendations must be read with the footnotes that follow.

5 For those who fall behind or start late, provide catch-up vaccination at the earliest opportunity as indicated by the green bars in Figure 1. To determine minimum intervals between doses, see the catch-up Schedule (Figure 2). School entry and Adolescent vaccine age groups are shaded in : The above recommendations must be read along with the footnotes of this Schedule . VaccineBirth1 mo2 mos4 mos6 mos9 mos12 mos15 mos18 mos19-23 mos2-3 yrs4-6 yrs7-10 yrs11-12 yrs13-15 yrs16 yrs17-18 yrsHepatitis B1 (HepB)Rotavirus2 (RV) RV1 (2-dose series); RV5 (3-dose series)Diphtheria, tetanus, & acellular pertussis3 (DTaP: <7 yrs)Haemophilus influenzae type b4 (Hib)Pneumococcal conjugate5 (PCV13)Inactivated poliovirus6 (IPV: <18 yrs)Influenza7 (IIV) Measles, mumps, rubella8 (MMR)Varicella9 (VAR)Hepatitis A10 (HepA) Meningococcal11 (MenACWY-D >9 mos.)

6 MenACWY-CRM 2 mos) Tetanus, diphtheria, & acellular pertussis13 (Tdap: >7 yrs)Human papillomavirus14 (HPV)Meningococcal B12 Pneumococcal polysaccharide5 (PPSV23)2nd dose1st doseSee footnote 11 See footnote 14 Annual vaccination (IIV) 1 or 2 dosesSee footnote 5 TdapSee footnote 22nd dose1st dose4th dose3rd dose2nd dose1st dose2-dose series, See footnote 104th dose3rd dose2nd dose1st dose2nd dose1st dose3rd or 4th dose, See footnote 4 See footnote 42nd dose1st dose2nd dose1st dose5th dose4th dose3rd dose2nd dose1st dose3rd dose2nd dose1st doseAnnual vaccination (IIV)

7 1 dose onlySee footnote 8 See footnote 12No recommendationRange of Recommended ages for certain high-risk groupsRange of Recommended ages for all childrenRange of Recommended ages for catch-up immunizationRange of Recommended ages for non-high-risk groups that may receive vaccine , subject to individual clinical decision makingFIGURE 2. Catch-up Immunization Schedule for persons aged 4 months 18 years who start late or who are more than 1 month behind United States, figure below provides catch-up schedules and minimum intervals between doses for children whose vaccinations have been delayed.

8 A vaccine series does not need to be restarted, regardless of the time that has elapsed between doses. Use the section appropriate for the Child s age. Always use this table in conjunction with Figure 1 and the footnotes that age 4 months through 6 yearsVaccineMinimum Age for Dose 1 Minimum Interval Between DosesDose 1 to Dose 2 Dose 2 to Dose 3 Dose 3 to Dose 4 Dose 4 to Dose 5 Hepatitis B1 Birth4 weeks8 weeks and at least 16 weeks after first dose. Minimum age for the final dose is 24 weeksMaximum age for first dose is 14 weeks, 6 days4 weeks4 weeks2 Maximum age for final dose is 8 months, 0 , tetanus, and acellular pertussis36 weeks4 weeks4 weeks6 months6 months3 Haemophilus influenzae type b46 weeks4 weeks if first dose was administered before the 1st weeks (as final dose)

9 If first dose was administered at age 12 through 14 further doses needed if first dose was administered at age 15 months or weeks4 if current age is younger than 12 months and first dose was administered at younger than age 7 months, and at least 1 previous dose was PRP-T (ActHib, Pentacel, Hiberix) or weeks and age 12 through 59 months (as final dose)4 if current age is younger than 12 months and first dose was administered at age 7 through 11 months; OR if current age is 12 through 59 months and first dose was administered before the 1st birthday, and second dose administered at younger than 15 months; OR if both doses were PRP-OMP (PedvaxHIB.)

10 Comvax) and were administered before the 1st further doses needed if previous dose was administered at age 15 months or weeks (as final dose) This dose only necessary for chil-dren age 12 through 59 months who received 3 doses before the 1st conjugate56 weeks4 weeks if first dose administered before the 1st weeks (as final dose for healthy children)if first dose was administered at the 1st birthday or further doses needed for healthy children if first dose was administered at age 24 months or weeks if current age is younger than 12 months and previous dose given at <7 months weeks (as final dose for healthy children) if previous dose given between 7-11 months (wait until at least 12 months old).